Tag Archives: CREE

Tuesday’s Midday Movers: uniQure NV (QURE), Cree (CREE), Royal Gold (RGLD), United States Steel (X), Intercept Pharma (ICPT)

So far Tuesday, October 15, NASDAQ is up 2.56% and the S&P is up 2.17%. Here are this morning’s most active stocks: uniQure NV (QURE – Research Report), Cree (CREE – Research Report), Royal Gold (RGLD – Research Report), United

Wednesday’s Midday Stock Update: Samsung Electronics (SSNLF), Cree (CREE), Akorn (AKRX), TrovaGene (TROV), Can-Fite BioPharma (CANF)

So far Wednesday, August 21, NASDAQ is up 0.22% and the S&P is up 0.1%. Here are this morning’s most active stocks: Samsung Electronics (SSNLF – Research Report), Cree (CREE – Research Report), Akorn (AKRX – Research Report), TrovaGene (TROV

Thursday’s Midday Stock Update: Weatherford (WFT), Cree (CREE), Rockwell Med (RMTI), Anthera Pharmaceuticals (ANTH), On Deck Capital Inc (ONDK)

So far Thursday, May 2, NASDAQ is down -1.4% and the S&P is down -0.72%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Weatherford (WFT – Research Report), Cree (CREE – Research Report),

What Made Oppenheimer Downgrade Cree’s Stock?

In a report released today, Colin Rusch from Oppenheimer downgraded Cree (CREE – Research Report) to Hold. The company’s shares closed yesterday at $64.78, close to its 52-week high of $69.21. Rusch commented: “We step to the sidelines on CREE

Oppenheimer Believes Cree (NASDAQ: CREE) Won’t Stop Here

Oppenheimer analyst Colin Rusch reiterated a Buy rating on Cree (CREE – Research Report) today and set a price target of $63. The company’s shares opened today at $55.38, close to its 52-week high of $57.51. Rusch noted: “This morning,

Cree (CREE) Receives a Buy from BMO Capital

BMO Capital analyst Ambrish Srivastava maintained a Buy rating on Cree (CREE – Research Report) yesterday and set a price target of $55. The company’s shares closed yesterday at $42.84. According to TipRanks.com, Srivastava is a 5-star analyst with an